Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis

Tetsuya Akaishi, Toshiyuki Takahashi, Ichiro Nakashima

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Multiple sclerosis (MS) is a demyelinating neurological disease with unknown causes. In this study, we comprehensively studied blood cell counts in the early phase of MS and compared their values with eventual prognostic variables. We found that the blood monocyte count in the early phase of MS was robustly associated with the clinical severity of MS (rho = 0.64; p = 0.0002) but that the counts of the other blood cells were not associated with severity. This correlation between monocyte count and severity was not observed in neuromyelitis optica. In conclusion, blood monocytes could be a candidate for the prognostic prediction of MS.

Original languageEnglish
Pages (from-to)37-40
Number of pages4
JournalJournal of Neuroimmunology
Publication statusPublished - 2018 Jun 15


  • Aggravating factor
  • Monocyte
  • Multiple sclerosis
  • Prognosis
  • Severity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis'. Together they form a unique fingerprint.

Cite this